Metropolitan Life Insurance Company (MetLife)’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-235
| Closed | -$931 | – | 1528 |
|
|
2024
Q1 | $931 | Sell |
235
-1,312
| -85% | -$5.2K | ﹤0.01% | 2300 |
|
|
2023
Q4 | $7.69K | Hold |
1,547
| – | – | ﹤0.01% | 2250 |
|
|
2023
Q3 | $7.81K | Hold |
1,547
| – | – | ﹤0.01% | 2321 |
|
|
2023
Q2 | $7.78K | Buy |
+1,547
| New | +$7.78K | ﹤0.01% | 2407 |
|
|
2018
Q2 | – | Sell |
-355
| Closed | -$8.38K | – | 2484 |
|
|
2018
Q1 | $8.38K | Buy |
+355
| New | +$8.38K | ﹤0.01% | 2470 |
|